中文名称:奥拉替尼
中文别名:N-二甲基-1-((1R,4R)-4-甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)环己基)甲磺酰胺;奥克西替尼;N-甲基-1-(反式-4-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)环己基)甲磺酰胺
英文名称:Oclacitinib
英文同义词:PF-03394197 (oclacitinib);Oclacitinib PF-03394197;JAKi;trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-cyclohexanemethanesulfonamide;CyclohexaneMethanesulfonaMide, N-Methyl-4-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-, trans-;N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide;N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide;Oclacitinib
CAS号:1208319-26-9
分子式:C15H23N5O2S
分子量:
规格含量：99%
包装规格：25kg/桶
用途：奥拉替尼是一种新型Janus激酶（JAK）抑制剂，具有抗过敏相关细胞因子的活性。适用于医药类